PHARMACOLOGY OF GABA RHO-1 AND GABA ALPHA BETA RECEPTORS EXPRESSED INXENOPUS OOCYTES AND COS CELLS/

Citation
T. Kusama et al., PHARMACOLOGY OF GABA RHO-1 AND GABA ALPHA BETA RECEPTORS EXPRESSED INXENOPUS OOCYTES AND COS CELLS/, British Journal of Pharmacology, 109(1), 1993, pp. 200-206
Citations number
24
Categorie Soggetti
Pharmacology & Pharmacy
ISSN journal
00071188
Volume
109
Issue
1
Year of publication
1993
Pages
200 - 206
Database
ISI
SICI code
0007-1188(1993)109:1<200:POGRAG>2.0.ZU;2-D
Abstract
1 The rho1 protein, which we previously cloned from retina, assembles as a homooligomer that transduces the binding of gamma-aminobutyric ac id (GABA) into robust chloride currents. However, its insensitivity to bicuculline, pentobarbitone and benzodiazepines, all potent agents at typical GABA(A) receptors, suggested that it may react atypically to other GABA agonists and antagonists. 2 cDNAs for the rho1 and the alph a,beta1 receptors for GABA were expressed as homo- and heterooligomers , respectively, in Xenopus oocytes. The selectivities of the respectiv e receptors for various agonists were investigated using concentration -response experiments in voltage clamped cells. 3 The most potent agon ists at the rho1 receptor were trans-4-aminocrotonic acid (TACA) > GAB A > muscimol; at the alpha5beta1 receptor the rank order was muscimol > GABA > 4,5,6,7-tetrahydro-isoxazole[4,5-c]pyridine-3-ol (THIP). The most specific agonists were cis-(2-(aminomethyl)-cyclopropyl-carboxyli c acid (CAMP) and THIP for the rho1 and the alpha5beta1 receptors, res pectively. 4 Comparing GABA, TACA and cis-aminocrotonic acid (CACA) at rho1 receptors expressed in COS cells gave results almost indistingui shable from those found at oocytes; the pharmacology of rho1 seems ind ependent of the expression system. 5 Agonists THIP, piperidine-4-sulph onic acid (P4S), and isoguvacine, whose C-C-C-N chains are constrained by rings into a folded conformation and were potent at the alpha5beta 1 receptor, were among the weakest at the rho1 receptor. However CACA and CAMP, which align better with the extended than the folded conform ation, were weakest at the alpha5beta1 receptor but moderately potent at the rho1 receptor. These findings suggest that the rho1 receptor re cognizes agonists in the extended conformation, in contrast to GABA(A) receptors, which are believed to recognize agonists in the partially folded conformation. 6 In contrast to the alpha5beta1 receptor, gradat ions in maximum responses were apparent in the rho1 receptor, suggesti ng various degrees of partial agonism. In particular, imidazole-4-acet ic acid (14AA), whose maximum response was only 3% of GABA's maximum, had an apparent K(d) for activating the rho1 receptor of 16 mum; but i t had an apparent K(d) for competitively blocking the receptor of 0.64 mum. This difference suggests that steric constraints in the activate d (open channel) receptor are tighter than in the resting receptor. 7 Hill coefficients approached 2 at the rho1 receptor, but were closer t o unity at the alpha5beta1 receptor. Thus, the rho1 receptor displayed higher cooperativity. 8 Unlike typical GABA(A) receptors, the rho1 re ceptor was insensitive to the competitive antagonists bicuculline, SR9 5531, securinine, and (+)-tubocurarine.